Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy

    Access Status
    Fulltext not available
    Authors
    Blaxill, J.
    Buzzacott, Peter
    Finlay, J.
    Date
    2021
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Blaxill, J. and Buzzacott, P. and Finlay, J. 2021. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy. Veterinary and Comparative Oncology. 20( 1): pp. 215- 226.
    Source Title
    Veterinary and Comparative Oncology
    DOI
    10.1111/vco.12768
    ISSN
    1476-5810
    Faculty
    Faculty of Health Sciences
    School
    Curtin School of Nursing
    URI
    http://hdl.handle.net/20.500.11937/87885
    Collection
    • Curtin Research Publications
    Abstract

    Lomustine, vincristine, procarbazine and prednisolone (LOPP) chemotherapy has been suggested to be an effective treatment for dogs with naïve non-indolent T-cell lymphoma (TCL). Studies evaluating prognostic factors for dogs with TCL treated with LOPP chemotherapy are lacking. The aim of this retrospective study was to assess potential prognostic factors for canine naïve non-indolent TCL treated with the LOPP protocol. This was a retrospective cohort study of naïve non-indolent TCL treated with the LOPP chemotherapy protocol at a single specialty veterinary oncology clinic. Sixty-seven dogs met the inclusion criteria. The outcomes assessed included progression free survival (PFS), overall survival time (OST) and duration of complete response (DCR). The overall median PFS was 118 days (range 7–2302 days). The median OST was 202 days (range 8–2302 days). The overall median DCR was 316 days (range 38–2261 days). Number of treatments administered (p <.0001), multicentric disease (p =.044) and the presence of hypercalcaemia (p =.006) were prognostic indicators for PFS. Increasing number of treatments (p <.0001) and age (p =.0088) were prognostic indicators for OST. To our knowledge, this is the first study to describe hypercalcaemia as a positive prognostic indicator of PFS for TCL treated with LOPP chemotherapy. LOPP chemotherapy can be considered as a first-line treatment protocol against naïve hypercalcaemic non-indolent TCL.

    Related items

    Showing items related by title, author, creator and subject.

    • Nottingham clinico-pathological response index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer
      Abdel-Fatah, T.; Ball, G.; Lee, A.; Pinder, S.; MacMilan, R.; Cornford, E.; Moseley, P.; Silverman, R.; Price, J.; Latham, B.; Palmer, D.; Chan, Arlene; Ellis, I.; Chan, S. (2015)
      © 2014 AACR. Purpose: There is a need to identify more sensitive clinicopathologic criteria to assess the response to neoadjuvant chemotherapy (Neo-ACT) and guide subsequent adjuvant therapy. Experimental Design: We ...
    • Two-Year Outcomes of "Treat and Extend" Intravitreal Therapy for Neovascular Age-Related Macular Degeneration
      Arnold, J.; Campain, A.; Barthelmes, D.; Simpson, J.; Guymer, R.; Hunyor, A.; McAllister, I.; Essex, R.; Morlet, Nigel; Gillies, M. (2014)
      Purpose: To report 24-month outcomes of anti-vascular endothelial growth factor (VEGF) therapy for treatment-naïve eyes with neovascular age-related macular degeneration (nAMD) using a treat and extend treatment regimen ...
    • Prognostic factors for malignant pleural mesothelioma
      Brims, Fraser; Maskell, N. (2013)
      The prognosis for patients with malignant pleural mesothelioma (MPM) is generally regarded as poor, although rare cases of long-term survivors are recognised. Previous prognostic scoring systems have been based on clinical ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.